FAMILY MEDICINE APPROACH TO LEPROSY PATIENT WITH DIABETES MELLITUS
DOI:
https://doi.org/10.31004/prepotif.v9i3.51977Keywords:
Leprosy, Diabetes Mellitus, Leprosy related diabetic, Family Medicine Approach, Holistic and Comprehensive ManagementAbstract
Kusta, juga dikenal sebagai penyakit Hansen, masih menjadi tantangan kesehatan global yang signifikan. WHO melaporkan 182.815 kasus kusta baru secara global pada tahun 2023. Penelitian di Kuwait menunjukkan bahwa sekitar 13,3% pasien kusta adalah DM, dengan tambahan 37,7% di negara-negara pra-DM. Lebih lanjut, respons imun seluler terhadap Mycobacterium leprae terganggu secara signifikan pada pasien DM, menciptakan lingkaran setan di mana DM mengganggu hasil pengobatan kusta sementara proses inflamasi terkait kusta dapat mempercepat atau memperburuk kontrol glikemik. Kami melakukan lima kunjungan rumah pada bulan Februari-Maret 2025 sebagai tatalaksana komprehensif dengan pendekatan kedokteran keluarga untuk pasien kusta dengan DM di wilayah Puskesmas Legok. Kami menyediakan intervensi yang berfokus pada pasien, intervensi pendekatan keluarga, dan intervensi pendekatan komunitas. Setelah kami menerapkan semua rencana terapi holistik dan komprehensif pada pasien dalam lima kunjungan rumah, kami menemukan adanya penurunan kadar gula darah, meskipun nilainya masih di atas nilai normal. Pasien kini memahami penyakitnya, melanjutkan pengobatan, dan minum obat secara teratur. Pasien juga mulai menjaga pola makan sehat dan mengurangi asupan kopi sachet hariannya, serta mulai menerima kondisinya. Kasus kompleks ini menunjukkan peran penting kedokteran keluarga dalam memberikan perawatan komprehensif dan terkoordinasi yang menangani berbagai kondisi kesehatan yang saling terkait dalam konteks kondisi sosial pasien dan dinamika keluarga.References
American Academy of Family Physicians [AAFP]. (2024). Family Medicine, Definition of. AAFP [serial online]. https://www.aafp.org/about/policies/all/family-medicine-definition.html
Azhary, H., Farooq, M.U., Bhanushali, M., Majid, A., Kassab, M.Y. (2010). Peripheral Neuropathy: Differential Diagnosis and Management. American Family Physician, 81(7), 887-892. https://www.aafp.org/pubs/afp/issues/2010/0401/p887.html
Beladina, N., & Adisasmita, A. (2021). Diabetic Status of People Affected by Leprosy in Donorojo Leprosy Recovered Village: A Cross Sectional Study. Jurnal Epidemiologi Kesehatan Komunitas, 6(1), 191-199. https://doi.org/10.14710/jekk.v6i1.9235
De Bruin, W., Dijkkamp, E., Post, E., & Van Brakel, W. H. (2013). Combining peer-led self-care interventions for people affected by leprosy and diabetes patients in leprosy-endemic countries. What do health care professionals think?. Leprosy Review, 84, 266-282. https://leprosyreview.org/admin/public/api/lepra/website/getDownload/5f7a9be02bea3004630efda9
Figueres-Pesudo, B., Pinargote-Celorio, H., Belinchón-Romero, I., & Ramos-Rincón, J. M. (2024). Comorbidities and Complications in People Admitted for Leprosy in Spain, 1997-2021. Life (Basel, Switzerland), 14(5), 586. https://doi.org/10.3390/life14050586
Ghosh, A. (2019). A Central India Perspective on Leprosy and Its Association with Diabetes Mellitus. Journal of Social Health and Diabetes, 7(1), 37-38. https://doi.org/10.1055/s-0039-1692334
Goulart, I. M. B., Santana, M. A. O., Costa, W. V. T. D., Pavelka, M. M., & Dornelas, B. C. (2022). Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy. IDCases, 27, e01386. https://doi.org/10.1016/j.idcr.2022.e01386
Hashim, M. J. (2018). A Definition of Family Medicine and General Practice. Journal of the College of Physicians and Surgeons Pakistan, 28(1), 76-77. https://jcpsp.pk/archive/2018/Jan2018/22.pdf
Jamoulle, M., Resnick, M., Vander Stichele, R., Ittoo, A., Cardillo, E., & Vanmeerbeek, M. (2017). Analysis of definitions of general practice, family medicine, and primary health care: a terminological analysis. BJGP open, 1(3), bjgpopen17X101049. https://doi.org/10.3399/bjgpopen17X101049
Nagar, R., Khare, S., & Sengar, S. S. (2015). Effectiveness of Methotrexate in prednisolone and thalidomide resistant cases of Type 2 leprosy reaction: report on three cases. Leprosy Review, 86, 378-382. https://leprosyreview.org/admin/public/api/lepra/website/getDownload/5f5116402bea3019717a7cec
Nasir, A., Yusuf, A., Listiawan, M. Y., & Makhfudli, M. (2022). The life experience of leprosy families in maintaining interaction patterns in the family to support healing in leprosy patients in Indonesian society. A phenomenological qualitative study. PLoS neglected tropical diseases, 16(4), e0010264. https://doi.org/10.1371/journal.pntd.0010264
Nigam, P., Dayal, S.G., Srivastava, P., Joshi, L.D., Goyal, B.M., Dutt, B., Gupta, M.C. (1979). Diabetic status in leprosy. Hansen International, 4(1), 7-14. http://hansen.bvs.ilsl.br/textoc/hansenint/v01aov20/1979/PDF/v4n1/v4n1a01.pdf
Prakoeswa, C.R.S., Lubis, R.S., Anum, Q., Argentina, F., Menaldi, S.L., Gunawan, H., … & Listiawan, M.Y. (2022). Epidemiology of Leprosy in Indonesia: a Retrospective Study. Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology, 34(1), 29-35. https://doi.org/10.20473/bikk.V34.1.2022.29-35
Pratama, N., Rusyati, L.M.M., Sudarsa, P.S.S., Karmila, I.G.A.A.D., Karna, N.L.P.R.V. (2022). Borderline Lepromatous Leprosy with Severe Erythema Nodosum Leprosum: A Case Report. Berkala Ilmu kesehatan Kulit dan Kelamin-Periodical Dermatology and Venereology Journal, 34(3), 210-216. https://e-journal.unair.ac.id/BIKK/article/view/30715
Rao, P. N., & Suneetha, S. (2018). Current Situation of Leprosy in India and its Future Implications. Indian Dermatology Online Journal, 9(2), 83–89. https://doi.org/10.4103/idoj.IDOJ_282_17
Saraya, M.A., Al-Fadhli, M.A., Qasem, J.A. (2012). Diabetic status of patients with leprosy in Kuwait. Journal of Infection and Public Health, 5(5), 360-365. https://doi.org/10.1016/j.jiph.2012.08.001
Trujillo-Ramirez, L., Palacios-Ariza, M. A., Pradilla, I., & Gamboa, L. A. (2021). Peripheral neuropathy in leprosy: Clinical manifestations and disability in a Colombian national referral center. Dermatology reports, 14(2), 9308. https://doi.org/10.4081/dr.2021.9308
World Health Organization. (2020). Leprosy/Hansen Disease: Management of reactions and prevention of disabilities. WHO [serial online]. https://iris.who.int/bitstream/handle/10665/332022/9789290227595-eng.pdf?sequence=1
World Health Organization. (2022). Global leprosy (Hansen disease) update, 2021: Moving towards interruption of transmission. WHO Weekly Epidemiological Record, 97(36), 429-450. https://www.who.int/publications/i/item/who-wer9736-429-450
World Health Organization. (2024). Leprosy (Hansen's disease). WHO The Global health Observatory [serial online]. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/leprosy
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Masali Almahdin, Novendy Novendy
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
